Literature DB >> 3677350

Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction.

M Isobe1, R Nagai, S Ueda, H Tsuchimochi, H Nakaoka, F Takaku, T Yamaguchi, K Machii, M Nobuyoshi, Y Yazaki.   

Abstract

To estimate the extent of myocardial infarction after coronary artery reperfusion, serum levels of cardiac myosin light chain (LC) I and creatine kinase (CK) were determined serially in 49 patients with acute myocardial infarction. Intracoronary thrombolysis was successful in 25 patients (reperfusion group), and 24 patients were treated in a conventional manner (control group). The peak level of CK appeared significantly earlier in the reperfusion group (11.3 +/- 3.1 hr, mean +/- SD) than in the control group (21.6 +/- 7.2 hr). Cumulative release of CK was significantly related to angiographically determined left ventricular ejection fraction 1 month after the attack in both groups (r = -.50; -.45, respectively). However, the amount of cumulative release of CK in the reperfusion group was greater compared with that in those with the same left ventricular ejection fraction in the control group. Peak appearance time of LCI was almost equal in the two groups (3.8 +/- 1.4 vs 3.9 +/- 1.2 days). Peak levels of LCI were related to the left ventricular ejection fraction in the reperfusion group (r = -.63) and in the control group (r = -.74), and the slopes of their regression lines were similar. The cardiac index obtained on the day of onset in the two groups was related to peak levels of LCI but not to total release of CK. These results suggest that serum levels of LCI reflect the changes in left ventricular function after acute myocardial infarction, regardless of the presence of coronary reperfusion. Thus, serial determinations of LCI in serum facilitate noninvasive assessment of the effects of intracoronary thrombolysis on infarct size.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3677350     DOI: 10.1161/01.cir.76.6.1251

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Myocardial uptake of antimyosin antibody compared with serum myosin light chain I levels in patients with myocardial infarction.

Authors:  M Suehiro; M Fukuchi; H Naruse; T Iwasaki
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

2.  Serum myosin light chain determinations in patients with inflammatory myopathy--a preliminary report.

Authors:  R Mader; R Pauzner; E C Keystone; P D Nicol; V J Sehgal; J J Turley
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

3.  An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression.

Authors:  Ling Yu; Read Allen; Lin Jia; Ting Sun; Steven J Isakoff; Marielle Scherrer-Crosbie; Allison M Kehlmann; Hui Zheng; Amy Ly; Charlotte S Walmsley; Katherine Hesler; Ava N Varasteh; Christopher J Pinto; Daniel E McLoughlin; Wenjin Wu; Xinhui Wang
Journal:  Front Oncol       Date:  2022-05-03       Impact factor: 5.738

4.  Circulating myosin light chain I levels after coronary reperfusion: a comparison with myocardial necrosis evaluated from single photon emission computed tomography with pyrophosphate.

Authors:  H Yoshida; M Mochizuki; K Sakata; M Takezawa; Y Matsumoto; M Yoshimura; N Mori; S Yokoyama; T Hoshino; T Kaburagi
Journal:  Ann Nucl Med       Date:  1992-02       Impact factor: 2.668

5.  Biochemical markers of myocardial injury.

Authors:  P K Nigam
Journal:  Indian J Clin Biochem       Date:  2007-03

6.  Increase in serum cardiac myosin light chain I associated with elective percutaneous transluminal coronary angioplasty in patients with ischemic heart disease.

Authors:  H Tanaka; K Gotoh; Y Yagi; T Tanaka; K Yamashita; T Suzuki; S Hirakawa
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

Review 7.  Biochemical markers of myocyte injury in heart failure.

Authors:  Y Sato; T Kita; Y Takatsu; T Kimura
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

8.  Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction.

Authors:  Aslan T Turer; Kenneth W Mahaffey; Dianne Gallup; W Douglas Weaver; Robert H Christenson; Nathan R Every; E Magnus Ohman
Journal:  Curr Control Trials Cardiovasc Med       Date:  2005-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.